Rheumatoid Arthritis Tied to Heavy Economic and Human Burdens
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 3, 2024 -- Rheumatoid arthritis (RA) is associated with higher health care expenditures and suboptimal quality of life in U.S. adults, according to a study published online Aug. 6 in ACR Open Rheumatology.
Yinan Huang, Ph.D., from the University of Mississippi in Oxford, and colleagues estimated the economic and humanistic burden of RA among U.S. adults using self-reported data from the Medical Expenditure Panel Survey (2018 to 2020).
The researchers found significantly higher total annual health care expenditures in the RA group versus the non-RA group (mean, $3,382.971). The RA group also had lower Short Form 12 Health Survey physical component summary scores (mean, 4.78) and lower mental component summary scores (mean, −0.84). Compared with the non-RA group, the RA group also had increased odds of requesting assistance with activities of daily living (adjusted odds ratio, 2.02) and instrumental activities of daily living (adjusted odds ratio, 2.11).
"RA was associated with higher health care expenditures, particularly prescription medication costs, and was associated with suboptimal quality of life," the authors write. "Prescribers should evaluate the health-related quality-of-life impact in prescribing treatment to adults with RA. Managed care professionals and payers should be aware of the high expenditures of RA due to high-cost prescription medications."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Higher Traffic-Related Air Pollution Exposure Tied to Depression
WEDNESDAY, Jan. 29, 2025 -- Exposure to traffic-related air pollution (TRAP) is associated with depression in women, possibly via reproductive health, according to a study...
Recent Decades Saw Rise in Sedative, Hypnotic, Anxiolytic Use Disorders
FRIDAY, Jan. 24, 2025 -- Diagnoses of sedative, hypnotic, or anxiolytic use disorders (SHA-UD) increased threefold to fivefold between 2001 and 2019 for adolescent and young adult...
Medical Use of Cannabis Tied to Higher Prevalence of Cannabis Use Disorder
THURSDAY, Jan. 23, 2025 -- Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis use disorder (CUD) than...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.